Connect with us
  • Elysium


Melo: how we’re revolutionising brain injury care



Melo has been developed to help facilitate better decisions around behavioural management. Photo: Melo

A new digital platform for managing behavioural assessments in neurorehabilitation is aiming to improve the lives of up to 10 million patients, clinicians and carers over the next 10 years. NR Times finds out more. 

Inadequate understanding of behavioural risks among brain injury patients is estimated to cost the NHS £2.5 billion a year through adverse incidents and staff turnover.

Current behavioural risk assessments are typically carried out on paper, but wards and staff are extremely busy and this data collection is often slow and inconsistent. 

To tackle this, award-winning health tech company, Decently, has developed a new platform which aims to streamline and simplify these assessments, using data to support clinicians in making evidence-based care decisions and ultimately, reduce the impact and number of incidents of challenging to manage behaviour. 

Over the last 15 months, MeloTM, has been developed and rolled out among clinicians at Salford Royal Hospital, to help facilitate better decisions around behavioural management through intuitive data collection, visualisation and advanced analytics. 

Following a successful pilot programme, the company is now looking to expand into a number of NHS trusts and private healthcare organisations across the UK. Co-founder of Decently, James Burch, and Dr Alistair Teager, consultant clinical neuropsychologist at Salford Royal, tell us more. 

Read this and more exclusive content every day as an NR Times online subscriber. Just £2.99 a month, cancel anytime.

Login Join Now